Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 12:38 pm Sale | 2022-12-30 | 13G | Endo International plc ENDPQ | RENAISSANCE TECHNOLOGIES LLC | 0 0.000% | -15,109,161 (Position Closed) | Filing History |
| 2022-09-08 1:43 pm Sale | 2022-08-31 | 13G | Endo International plc ENDPQ | BlackRock Inc. BLK | 1,556,382 0.700% | -17,076,683 (-91.65%) | Filing |
| 2022-08-29 4:05 pm Purchase | 2022-08-17 | 13G | Endo International plc ENDPQ | Millennium Management LLC | 4,595,233 2.000% | 535,082 (+13.18%) | Filing History |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | Endo International plc ENDPQ | BlackRock Inc. BLK | 18,633,065 7.900% | -18,194,795 (-49.40%) | Filing |
| 2022-06-27 4:51 pm Purchase | 2022-06-17 | 13G | Endo International plc ENDPQ | Millennium Management LLC | 4,060,151 1.700% | 4,060,151 (New Position) | Filing History |
| 2022-02-14 4:39 pm Sale | 2021-12-31 | 13G | Endo International plc ENDPQ | PAULSON & CO. INC. | 17,327,012 7.400% | -1,000,000 (-5.46%) | Filing History |
| 2022-02-11 12:11 pm Sale | 2021-12-31 | 13G | Endo International plc ENDPQ | RENAISSANCE TECHNOLOGIES LLC | 15,109,161 6.470% | -4,490,064 (-22.91%) | Filing History |
| 2022-02-10 08:11 am Purchase | 2021-12-31 | 13G | Endo International plc ENDPQ | The Vanguard Group | 27,588,369 11.810% | 2,251,130 (+8.88%) | Filing History |
| 2022-01-27 5:13 pm Unchanged | 2021-12-31 | 13G | Endo International plc ENDPQ | BlackRock Inc. BLK | 36,827,860 15.800% | 0 (Unchanged) | Filing |
| 2022-01-26 09:16 am Purchase | 2021-12-31 | 13G | Endo International plc ENDPQ | BlackRock Inc. BLK | 36,827,860 15.800% | 113,161 (+0.31%) | Filing |
| 2021-02-16 5:02 pm Purchase | 2020-09-30 | 13G | Endo International plc ENDPQ | PAULSON & CO. INC. | 18,327,012 8.000% | 18,327,012 (New Position) | Filing History |
| 2021-02-16 4:13 pm Sale | 2020-12-31 | 13G | Endo International plc ENDPQ | GLENVIEW CAPITAL MANAGEMENT LLC | 7,497,768 3.260% | -10,980,637 (-59.42%) | Filing History |
| 2021-02-16 10:02 am Sale | 2020-12-31 | 13G | Endo International plc ENDPQ | MILLER VALUE PARTNERS LLC | 294,150 0.130% | -15,277,345 (-98.11%) | Filing History |
| 2021-02-11 07:21 am Purchase | 2020-12-31 | 13G | Endo International plc ENDPQ | RENAISSANCE TECHNOLOGIES LLC | 19,599,225 8.510% | 3,315,525 (+20.36%) | Filing History |
| 2021-02-10 10:52 am Sale | 2020-12-31 | 13G | Endo International plc ENDPQ | The Vanguard Group | 25,337,239 11.000% | -4,631,917 (-15.46%) | Filing History |
| 2021-01-25 4:56 pm Purchase | 2020-12-31 | 13G | Endo International plc ENDPQ | BlackRock Inc. BLK | 36,714,699 15.900% | 1,451,620 (+4.12%) | Filing |
| 2020-12-03 8:26 pm Sale | 2020-12-02 | 13D | BIOSPECIFICS TECHNOLOGIES CORP BSTC | Endo International plc ENDP | 100 100.000% | -934,973 (-99.99%) | Filing History |
| 2020-10-29 5:24 pm Purchase | 2020-10-19 | 13D | BIOSPECIFICS TECHNOLOGIES CORP BSTC | Endo International plc ENDP | 935,073 12.700% | 935,073 (New Position) | Filing History |
| 2020-02-14 4:11 pm Purchase | 2019-12-31 | 13G | Endo International plc ENDPQ | GLENVIEW CAPITAL MANAGEMENT LLC | 18,478,405 8.150% | 5,946,514 (+47.45%) | Filing History |
| 2020-02-14 2:27 pm Purchase | 2019-12-31 | 13G | Endo International plc ENDPQ | MILLER VALUE PARTNERS LLC | 15,571,495 6.870% | 15,571,495 (New Position) | Filing History |